Researchers engineered a CRISPR base editor to correct the ACTA2 mutation causing multisystemic smooth muscle dysfunction ...

Researchers have identified a molecular biomarker in triple negative breast cancer tumours which could inform when beta blockers can play a role in 'switching off' tumour progression.

CRISPRgenee is a new method that combines gene silencing and cutting to improve loss-of-function studies in human cells.